Manager, Trial Supply Management
Bristol-Myers Squibb
- Location
- Princeton NJ, US
- Work model
- On-Site
- Level
- Mid
- H-1B history
- 57 approvals (FY2023)
- Posted
- 21h ago
About this role
Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us . The Manager, Trial Supply Management executes supply strategies for all investigational product based on the scientific and regulatory confines of the drug’s development with minimal supervision.
Key Responsibilities
Collaborates with internal Global Clinical Supply Chain (GCSC) teams and external Customers and Service Providers, including but not limited to Global Drug Development, Pharmaceutical Development, Product Development Quality (PDQ), External Vendors and Medical to ensure all needs are met. Partners with the Clinical Supply Lead (CSL) in planning and communicating the clinical supply chain strategy in support of global clinical studies to promote optimal use and alignment with study and corporate goals. Demonstrates strong knowledge of GCSC processes when presenting at cross-functional meetings. Contributes to strategies for continuous improvement, both departmental and/or inter-departmental. Influences clinical and development timelines, study design and country selection. Responsible for reviewing and working with the CSL to provide any contributions to the clinical protocol and directly responsible for protocol amendments, communicating timelines and investigational product strategies to study and cross-functional teams Monitors inventory and analyzes drug utilization versus forecast taking into account country requirements and logistical timelines. Issues Packaging/Labeling requests to Clinical Supply Operations (CSO) in alignment with RDSC Master Planning timelines and based on collaboration with CSO Packaging and Labeling to ensure package design and clinical label for investigational product meet protocol and regulatory requirements. Monitor use date of investigational drug product for assigned protocols. Support use date extension activities, such as generation of Use Date Extension (UDE) memo and provide feedback to Logistics team to support generation of UDE labels for depots and clinical sites. Derives enhancements to improve the timely delivery of quality clinical supplies for all assigned compounds and protocols by collaborating with internal and external sources while taking into account global and country Regulatory and QP Release requirements. Participates in development, review and approval of Interactive Response Technology (IRT) specifications. Executes investigational product distribution strategies and maintains distribution and supply strategies at depot and site level according to study and IRT requirements. Actively participates in internal Clinical Supply Chain meetings, Study Team meetings, Clinical Supply Matrix Team meetings and any other relevant meetings providing all relevant data and documentation prior to each meeting, highlighting any risks and mitigation strategies. Collaborates with Clinical Supply Strategic Sourcing team to procure commercial drug in alignment with country and clinical study requirements. Attends meetings with vendors and generates purchase requisitions as needed. Supports associated actions stemming from change controls. In